Clinical Trials Directory

Trials / Sponsors / Noven Therapeutics

Noven Therapeutics

Industry · 13 registered clinical trials.

StatusTrialPhaseStarted
CompletedIrritation and Sensitization Study of d-Amphetamine Transdermal System
Cumulative Irritation and Sensitization
Phase 12019-12-02
CompletedPharmacokinetic Evaluation of Brisdelle™ (Formerly Known as Mesafem) Following Single & Repeat Oral Administra
Postmenopausal Symptoms
Phase 12011-07-01
CompletedEfficacy/Safety Study of Brisdelle™ (Formerly Known as Mesafem) in the Treatment of Vasomotor Symptoms (VMS)
Postmenopausal Symptoms
Phase 32011-05-01
Completed24-Week Efficacy & Safety Study of Brisdelle™ (Formerly Known as Mesafem) in the Treatment of Vasomotor Sympto
Hot Flashes
Phase 32010-03-01
CompletedEight-Week Efficacy & Safety Study of Brisdelle™ (Formerly Known as Mesafem) in the Treatment of Vasomotor Sym
Hot Flashes
Phase 22008-11-01
CompletedEvaluate the Safety and Efficacy of Methylphenidate Transdermal System (MTS) in Adolescents Aged 13-17 Years W
ADHD
Phase 32007-08-01
CompletedEvaluate the Efficacy &Safety of Methylphenidate Transdermal System (MTS) in Adolescents Aged 13-17 Years With
ADHD
Phase 32007-07-01
CompletedCharacterization of Dermal Reactions in Pediatric Patients With ADHD Using DAYTRANA
Attention Deficit Hyperactivity Disorder
Phase 42007-01-01
CompletedSafety & Tolerability of MTS in Children Aged 6-12 Diagnosed With ADHD & Previously Treated With Extended-Rele
Attention Deficit Disorder With Hyperactivity
Phase 32005-06-01
CompletedEfficacy, Safety and Tolerability of SPD485 in Children Aged 6-12 Diagnosed With ADHD
Attention Deficit Disorder With Hyperactivity
Phase 22005-06-01
CompletedSafety and Tolerability of SPD485 in Children Aged 6-12 Diagnosed With ADHD and Previously Participated in MTS
Attention Deficit Disorder With Hyperactivity
Phase 32004-10-01
CompletedSafety and Efficacy of MTS Versus Concerta in Pediatric Patients (Aged 6-12 Years) With ADHD
Attention Deficit Hyperactivity Disorder
Phase 32004-09-01
CompletedClassroom Study to Assess Efficacy and Safety of MTS in Pediatric Patients Aged 6-12 With ADHD
Attention Deficit Disorder With Hyperactivity
Phase 22004-08-01